Money Concepts Capital’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,304
Closed -$1.05M 440
2023
Q1
$1.05M Sell
11,304
-2,439
-18% -$213K 0.06% 210
2022
Q4
$1.25M Buy
13,743
+1,485
+12% +$125K 0.06% 260
2022
Q3
$932K Buy
12,258
+11,334
+1,227% +$940K 0.06% 237
2022
Q2
$78K Sell
924
-2,081
-69% -$183K 0.01% 616
2022
Q1
$264K Buy
+3,005
New +$260K 0.01% 618

Other funds holding NVS

Money Concepts Capital's NVS Position: Q2 2023 in Review

Money Concepts Capital sold out of Novartis (NVS) in Q2 2023, closing a stake of 11,304 shares — an estimated $1.05M sold.

Money Concepts Capital first reported a position in NVS in Q1 2022 and held it in 5 quarters. The position peaked at $1.25M in Q4 2022. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

  • Money Concepts Capital reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
  • Money Concepts Capital sold 11,304 Novartis shares in Q2 2023, an estimated $1.05M.
  • Money Concepts Capital first reported a position in Novartis in Q1 2022 and held it in 5 quarters.
  • Money Concepts Capital's Novartis position peaked at $1.25M in Q4 2022.
  • 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on Money Concepts Capital's 13F filing for Q2 2023, filed 1 Aug 2023.